{{Chembox
| ImageFile = Bunitrolol.svg
| ImageSize = 200px
| ImageAlt = 
| ImageFile2 = Bunitrolol-3D-balls.png
| IUPACName = 2-[3-(''tert''-Butylamino)-2-hydroxypropoxy]benzonitrile
| OtherNames = 
|Section1={{Chembox Identifiers
| CASNo = 34915-68-9
| PubChem = 2473
| ChemSpiderID = 2379
| ChEMBL = 418134
| InChI = 1/C14H20N2O2/c1-14(2,3)16-9-12(17)10-18-13-7-5-4-6-11(13)8-15/h4-7,12,16-17H,9-10H2,1-3H3
| InChIKey = VCVQSRCYSKKPBA-UHFFFAOYAU
| StdInChI = 1S/C14H20N2O2/c1-14(2,3)16-9-12(17)10-18-13-7-5-4-6-11(13)8-15/h4-7,12,16-17H,9-10H2,1-3H3
| StdInChIKey = VCVQSRCYSKKPBA-UHFFFAOYSA-N
| SMILES = CC(C)(C)NCC(COC1=CC=CC=C1C#N)O}}
|Section2={{Chembox Properties
| C=14 | H=20 | N=2 | O=2
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards = 
| FlashPt = 
| AutoignitionPt = }}
}}

'''Bunitrolol''' is a [[beta-adrenergic antagonist]].<ref>{{cite journal|pmid=20310018|year=2010|last1=Haddad|first1=S|last2=Poulin|first2=P|last3=Funk|first3=C|title=Extrapolating in vitro metabolic interactions to isolated perfused liver: Predictions of metabolic interactions between R-bufuralol, bunitrolol, and debrisoquine|volume=99|issue=10|pages=4406â€“26|doi=10.1002/jps.22136|journal=Journal of pharmaceutical sciences}}</ref>

==References==
{{Reflist}}


{{Adrenergics}}

[[Category:Beta blockers]]
[[Category:Nitriles]]


{{organic-compound-stub}}
{{pharma-stub}}